Wegman Thomas 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Aug 2, 2018
Insider Transaction Report
Form 4
Wegman Thomas
DirectorPresident10% Owner
Transactions
- Conversion
Common Stock, $0.001 par value
2018-08-02$21.00/sh+50,000$1,050,000→ 336,327 total - Conversion
Stock Option (Right to Buy)
2018-08-02−50,000→ 0 totalExercise: $21.00From: 2018-08-02Exp: 2018-08-02→ Common Stock, $.001 par value (50,000 underlying)